UK pharma patents up 20%, new report finds
Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.
Extending patents is restricting patients’ access to the treatments they need.
IP management can protect pharma companies’ investments and future R&D.